YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy

NCT00048659 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Conditions

Hormone-Refractory Prostate Cancer
Prostatic Neoplasms

Interventions

DRUG: YM598

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]